We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Specific Antibody Indicates Route of Parasitic Infection

By LabMedica International staff writers
Posted on 02 Jun 2011
A protein that elicits an antibody to the parasite Toxoplasma gondii may help scientists determine the mode of transmission. More...


The T. gondii embryogenesis-related protein (TgERP) can be detected in the sera of humans and animals by difference gel electrophoresis, in combination with tandem mass spectroscopy and Western blot analysis.

A team of scientists, led by those at the Animal and Natural Resources Institute (Beltsville, MD, USA), selected a recombinant protein from a complementary DNA (cDNA) library constructed from T. gondii sporozoites and it was used for Western blots and probed with sera from T. gondii-infected humans. The investigators used blood sera from laboratory tests performed with pigs and mice, as well as human blood sera from six events of known occurrences of toxoplasmosis.

Serum antibody to the antigen TgERP was detected in humans within 6-8 months of initial oocyst-acquired infection. Of 163 individuals in the acute stage of infection, where anti–T. gondii immunoglobulin M (IgM) was detected in sera, or where the IgG avidity test was less than 30%, 103 (63.2%) had detectable antibodies that reacted with TgERP. Of 176 individuals with unknown infection route and in the chronic stage of infection, where no anti–T. gondii IgM was detected in sera, or with greater than 30% result in the IgG avidity test, antibody to TgERP was detected in 31(17.6%) samples.

The routes of infection include ingestion of food or water contaminated with oocysts from infected cat feces and ingestion of tissue cysts in undercooked or raw meat. Food animals, such as pigs, can also become infected, resulting in people consuming meat products containing tissue cysts. Congenital infection can bring about a range of outcomes for the child, including chronic infection, blindness, mental retardation, and stillbirth. Until now, no tests were able to differentiate between oocyst ingestion and tissue cyst ingestion as the infection source.

In these tests, antibody to TgERP was effectively identified in all pigs exposed to oocyte infection and 90% of people known or suspected to have been exposed to oocysts. The authors conclude that, "TgERP may be useful in detecting exposure to sporozoites in early Toxoplasma infection and implicates oocysts as the agent of infection." The study was published in April 2011, in the Journal of Parasitology.

Related Links:

Animal and Natural Resources Institute




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.